University Hospital Heidelberg

addHeidelberg, Germany
( 9/10 from votes )
Prof. Dr. Uwe Haberkorn

Head of the Department

Prof. Dr. Uwe Haberkorn

Department of Nuclear Medicine

Department of Nuclear Medicine at University Hospital Heidelberg provides the most advanced diagnostics and therapeutics for the treatment of more than 6,000 inpatients every year. The stations of the department are equipped with the latest technology leading to better management of thyroid, oncological, cardiological, and neurological disorders.
Under the guidance of Prof. Med. Uwe Haberkorn, the medical staff offers innovative measures for patients of malignant carcinoids such as PET, scintigraphy, MIBG therapy. Other available therapeutic measures include 90Y-labeled peptide therapy, which is preferable for neuroendocrine tumors treatment.

The Department of Nuclear Medicine at University Hospital Heidelberg is specialized in the diagnosis and treatment of:

  • Goiter
  • Hashimoto's thyroiditis
  • Thyroid enlargement
  • Thyroid carcinoma
  • Thyroid carcinoma
  • Thyroiditis de Quervai
  • Prostate cancer

Education and Professional Career

  • 1979 - 1982 Study of Philosophy and German Philology at the Heidelberg University, Study of Human Medicine at the Universities of Marburg, Wuerzburg and Heidelberg.
  • 1988 3rd State Examination, Heidelberg University.
  • 1988 Intern and admission to medical practice, Heidelberg University.
  • 1995 Medical Specialist in Nuclear Medicine.
  • 1988 Doctoral thesis defense, Heidelberg University.
  • 1996 Habilitation, Heidelberg University.
  • Head of the Department of Nuclear Medicine at the University Hospital Heidelberg, as well as the Head of the Nuclear Medicine Clinical Cooperation Unit at the German Cancer Research Center (DKFZ).

Clinical Focuses

  • Diagnostics and treatment of thyroid diseases.
  • Diagnostics and treatment of cancers.

Research Focuses

  • Gene transfer as a method for the treatment of malignant tumors.
  • The use of tumor-affinity peptides for the diagnostics and treatment of cancers.
  • Non-invasive apoptosis diagnostics.

Awards

  • 1996 Mallinckrodt Prize of the German Society for Nuclear Medicine.
  • 1998 1st Prize for Contrast Media Research from the German Radiological Society.
  • 2018 Erwin Schrödinger Prize.